Will T-cell therapy for cancer ever be a standard of care?

Research output: Contribution to journalReview article

12 Scopus citations

Abstract

Cellular therapies for cancer are showing increasing efficacy but their introduction as a 'standard of care' for these disorders is hampered by technical, regulatory and financial concerns. This review identifies some of the major problems and suggests potential solutions.

Original languageEnglish (US)
Pages (from-to)818-821
Number of pages4
JournalCancer Gene Therapy
Volume19
Issue number12
DOIs
StatePublished - Dec 1 2012

Keywords

  • cancer
  • commercialization
  • T-cell therapy

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Molecular Biology

Fingerprint Dive into the research topics of 'Will T-cell therapy for cancer ever be a standard of care?'. Together they form a unique fingerprint.

Cite this